This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Shenzhen Gosun Pharmaceutical Co., Ltd., Tianjin University. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2012
Title: Yuxin Qian: Innovator in Pharmaceutical Crystallization
Introduction
Yuxin Qian is a notable inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of crystallization methods for drug compounds. His innovative work has led to the development of a unique crystal form of cefazolin sodium pentahydrate.
Latest Patents
Yuxin Qian holds a patent for "Cefazolin sodium pentahydrate crystal and its molecular assembly preparation method." This invention relates to the preparation of cefazolin sodium pentahydrate crystal, which contains five water molecules and is characterized by an orthorhombic system with a space group of C222(1). The method involves adding a solvent to a reactor, incorporating cefazolin acid and a sodium salt, and controlling various parameters to achieve a crystal with adjustable particle size, good flowability, smooth surface, high crystallinity, and rapid dissolving rate.
Career Highlights
Throughout his career, Yuxin Qian has worked with prominent institutions such as Tianjin University and Shenzhen Gosun Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical research and development.
Collaborations
Yuxin Qian has collaborated with notable colleagues, including Jingkang Wang and Zhan'ao Yang. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Yuxin Qian's innovative work in the field of pharmaceutical crystallization exemplifies the importance of research and development in creating effective drug formulations. His contributions continue to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile